The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Initial analytic validation of automated bone scan measures for treatment response assessment in patients with metastatic castration-resistant prostate cancer (CRPC).
G. H. Chu
No relevant relationships to disclose
M. S. Brown
Employment or Leadership Position - MedQIA (U)
H. J. Kim
No relevant relationships to disclose
M. Auerbach
No relevant relationships to disclose
C. Poon
No relevant relationships to disclose
B. Ramakrishna
No relevant relationships to disclose
A. Vidovic
No relevant relationships to disclose
D. W. Gjertson
No relevant relationships to disclose
M. J. Morris
No relevant relationships to disclose
S. M. Larson
No relevant relationships to disclose
J. G. Goldin
Employment or Leadership Position - QIA Imaging Core (U)
H. I. Scher
No relevant relationships to disclose